Functional PAX-6 gene-linked polymorphic region: Potential association with paranoid schizophrenia

Biological Psychiatry

Volumn 45, Issue 12, 1999, Pages 1585-1591

  Stöber, Gerald ^a   Syagailo, Yana V ^a   Okladnova, Olga ^a   Jungkunz, Gerd ^b   Knapp, Michael ^c   Beckmann, Helmut ^a   Lesch, Klaus Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c NONE

Author keywords

Bipolar affective disorder; Gene; Linkage; Neurodevelopment; PAX 6; Polymorphism; Promoter; Repeat; Schizophrenia

Indexed keywords

ADULT; ARTICLE; BRAIN MATURATION; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

ADULT; ALLELES; BIPOLAR DISORDER; BRAIN; CASE-CONTROL STUDIES; CULTURE TECHNIQUES; FEMALE; GENES, REGULATOR; GENOTYPE; HETEROZYGOTE; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; NEURONAL PLASTICITY; POINT MUTATION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SCHIZOPHRENIA, PARANOID; TRANSCRIPTION, GENETIC; VARIATION (GENETICS);

EID: 2542507891     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00024-4     Document Type: Article

References (47)

1. Akbarian S., Kim J.J., Potkin S.G., Hetrick W.P., Bunney W.E., Jones E.G. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry. 53:1996;425-436.
2. Akil M., Lewis D.A. Cytoarchitecture of the entorhinal cortex in schizophrenia. Am J Psychiatry. 154:1997;1010-1012.
3. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;American Psychiatric Press, Washington, DC.
4. Arnold S.E., Ruscheinsky D.D., Han L.Y. Further evidence of abnormal cytoarchitecture of the entorhinal cortex in schizophrenia using spatial point pattern analyses. Biol Psychiatry. 42:1997;639-647.
5. Barbeau D., Liang J.J., Robitaille Y., Quirion R., Srivastava L.K. Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc Natl Acad Sci U S A. 92:1995;2785-2789.
6. Beckmann H., Jakob H. Prenatal disturbances of nerve cell migration in the entorhinal region A common vulnerability factor in functional psychoses? J Neural Transm. 84:1991;155-164.
7. Chalepakis G., Stoykova A., Wijnholds J., Tremblay P., Gruss P. Pax Gene regulators in the developing nervous system . J Neurobiol. 24:1993;1367-1384.
8. Cremer H., Lange R., Christoph A., Plomann M., Vopper G., Roes S., et al. Inactivation of the N-CAM gene in mice results in reduction of the olfactory bulb and in deficits in spatial learning. Nature. 367:1994;455-459.
9. Cvekl A., Piatigorsky J. Lens development and crystalline gene expression Many roles for PAX-6 . Bioassays. 18:1996;621-630.
10. Czerny T., Busslinger M. DNA-binding and transactivation properties of Pax-6 Three amino acids in the paired domain are responsible for the different sequence recognition of Pax-6 and BSAP (Pax-5) . Mol Cell Biol. 15:1995;2858-2871.
11. Edelman G.M., Jones F.S. Developmental control of N-CAM expression by Hox and Pax gene products. Philos Trans R Soc Lond Bio Sci. 349:1995;305-312.
12. Faraone S.V., Matise T., Svrakic D., Pepple J., Malaspina D., Suarez B., et al. Genome scan of European-American schizophrenia pedigrees Results of the NIMH Genetics Initiative and Millennium Consortium . Am J Med Genet. 81:1998;290-295.
13. Glaser T., Walton D.S., Maas R.L. Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene. Nature Genet. 2:1992;232-238.
14. Grindley J.C., Davidson D.R., Hill R.E. The role of Pax-6 in eye and nasal development. Development. 121:1995;1433-1442.
15. Holst B.D., Wang Y., Jones F.S., Edelman G.M. A binding site for Pax proteins regulates expression of the gene for the neural cell adhesion molecule in the embryonic spinal cord. Proc Natl Acad Sci U S A. 94:1997;1465-1470.
16. Jakob H., Beckmann H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm. 65:1996;303-326.
17. Katsetos C.D., Hyde T.M., Herman M.M. Neuropathology of the cerebellum in schizophrenia - an update 1996 and future directions . Biol Psychiatry. 42:1997;213-224.
18. Kelsoe J.R., Kristbjarnson H., Bergesch Pk, Shilling P., Hirsh S., Mirow A., et al. A genetic linkage study of bipolar disorder and 13 markers on chromosome 11 including the D2 dopamine receptor. Neuropsychopharmacology. 9:1993;293-301.
19. Kendler K.S., Davis L.D. The genetics and biochemistry of paranoid schizophrenia and other paranoid psychoses. Schizophr Bull. 7:1981;689-709.
20. Lesch K.P., Mössner R. Genetically driven variation in serotonin uptake Is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders . Biol Psychiatry. 44:1998;179-192.
21. Levinson D.F., Mahtani M.M., Nancarrow D.J., Brown D.M., Kruglyak L., Kirby A., et al. Genome scan of schizophrenia. Am J Psychiatry. 155:1998;741-750.
22. Macchia P.E., Lapi P., Krude H., Pirro M.T., Missero C., Chiovato L., et al. Pax8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat Genet. 19:1998;83-86.
23. Mastick G.S., Davis N.M., Andrews G.L., Easter S.S. Pax-6 functions in boundary formation and axon guidance in the embryonic mouse forebrain. Development. 124:1997;1985-1997.
24. McGlashan T.H., Fenton W.S. Classical subtypes for schizophrenia Literature review for DSM-IV . Schizophr Bull. 17:1991;609-647.
25. McInnis M.G., MacKinnon D.F., McMahon F.J., Foroud T., Edenberg H.J., Goate A., et al. Evidence for a susceptibility locus for bipolar disorder on chromosome 11p11.5. Am J Med Genet. 81:1998;463.
26. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
27. Moises H.W., Yang L., Kristbjarnson H., Wiese C., Byerley W., Macciardi F., et al. An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet. 11:1995;321-324.
28. Okladnova O., Syagailo Y.V., Mössner R., Riederer P., Lesch K.P. Regulation of PAX-6 gene transcription alternate promoter usage in human brain . Mol Brain Res. 60:1998;177-192.
29. Okladnova O., Syagailo Y.V., Tranitz M., Stöber G., Riederer P., Mössner R., et al. A promoter-associated polymorphic repeat modulates PAX-6 expression in human brain. Biochem Biophys Res Commun. 248:1998;402-405.
30. Osumi N., Hirota A., Ohuchi H., Nakafuku M., Iimura T., Kuratani S., et al. Pax-6 is involved in the specification of hindbrain motor neuron subtype. Development. 124:1997;2961-2972.
31. Read A.P. Pax genes - paired feet in three camps. Nat Genet. 9:1995;333-334.
32. Samochowiec J., Okladnova O., Syagailo Y., Rottmann M., Sander T., Smolka M., et al. No association between PAX-6 gene promoter polymorphism and alcohol dependence. Eur Arch Psychiatry Clin Neurosci. 248:(suppl 2):1998;117.
33. Schedl A., Ross A., Lee M., Engelkamp D., Rashbass P., van Heyningen V., et al. Influence of PAX-6 gene dosage on development Overexpression causes severe eye abnormalities . Cell. 86:1996;71-82.
34. Schmahmann J.D. An emerging concept. The cerebellar contribution to higher function. Arch Neurol. 48:1991;1178-1187.
35. Stine O.C., McMahon F.J., Chen L., Xu J., Meyers D.A., MacKinnon D.F., et al. Initial genome scan for bipolar disorder in the NIMH genetics initiative pedigrees Chromosome 2, 11, 13, 14 and X . Am J Med Genet. 74:1997;263-269.
36. Stöber G., Franzek E., Beckmann H. The role of maternal infectious diseases during pregnancy in the etiology of schizophrenia in offspring. Eur Psychiatry. 7:1992;147-152.
37. Stöber G., Jatzke S., Heils A., Jungkunz G., Knapp M., Mössner R., et al. Insertion/deletion variant (-141C Ins/Del) in the 5′ regulatory region of the dopamine D2 receptor gene Lack of association with schizophrenia and bipolar affective disorder . J Neural Transm. 105:1998;101-109.
38. Stöber G., Jatzke S., Heils A., Jungkunz G., Knapp M., Riederer P., et al. Susceptibility for schizophrenia is not influenced by a functional insertion/deletion variant in the promoter of the serotonin transporter gene. Eur Arch Psychiatry Clin Neurosci. 248:1998;82-86.
39. Stoykova A., Gruss P. Roles of Pax-genes in developing and adult brain as suggested by expression patterns. J Neurosci. 14:1994;1395-1412.
40. Stuart E.T., Gruss P. PAX genes What's new in developmental biology and cancer . Hum Mol Genet. 4:1995;1717-1720.
41. Tomasiewicz H., Ono K., Yee D., Thompson C., Goridis C., Rutishauser U., et al. Genetic deletion of a neural cell adhesion molecule variant (N-CAM-180) produces distinct defects in the central nervous system. Neuron. 11:1993;1163-1174.
42. Ton C.C.T., Hirvonen H., Miwa M.M., Monaghan P., Jordan T., van Heyningen V., et al. Positional cloning of a paired box- and homeobox-containing gene from the aniridia region. Cell. 67:1991;1059-1074.
43. Tsuang M.T., Faraone S.V. The case for heterogeneity in the etiology of schizophrenia. Schizophr Res. 17:1995;161-175.
44. Walther C., Gruss P. Pax-6, a murine paired box gene, is expressed in the developing CNA. Development. 113:1991;1435-1449.
45. Weinberger D.R. On the plausibility of "the neurodevelopmental hypothesis" of schizophrenia. Neuropsychopharmacology. 14:(suppl 3):1996;1-11.
46. Williams J., Farmer A.E., Ackenheil M., Kaufmann C.A., McGuffin P. A multicenter inter-rater reliability study using the OPCRIT computerized diagnostic system. Psychol Med. 26:1996;775-783.
47. Zalewski C., Johnson-Selfridge M.T., Ohriner S., Zarrella K., Seltzer J.C. A review of neuropsychological differences between paranoid and nonparanoid schizophrenia patients. Schizophr Bull. 24:1998;127-145.